Search the Newsreel

387,188 Shares in AngioDynamics, Inc. $ANGO Bought by Western Standard LLC

Western Standard LLC has acquired 387,188 shares of AngioDynamics, Inc. (NASDAQ:ANGO) for approximately $5.04 million, making it their 17th largest position. AngioDynamics recently beat quarterly earnings expectations, reporting a loss of $0.07 per share on $86.61 million in revenue, exceeding estimates despite remaining unprofitable. …

Servisfirst Bancshares To Carry Out 2-for-1 Stock Split On August 21st, 2026

Servisfirst Bancshares (NYSE:SFBS) has announced a 2-for-1 stock split, which will be distributed on August 21st, 2026. Shareholders will receive one additional share for each share they currently own. This action typically aims to increase stock liquidity and make shares more accessible to a …

Nurix Therapeutics Announces Appointment of Wes Burwell as Chief Human Resources Officer

Nurix Therapeutics has appointed Wes Burwell as its new Chief Human Resources Officer. Burwell brings over 20 years of HR leadership experience in the life sciences sector, with a strong background in scaling organizations through growth and preparing for commercialization. His appointment comes as …

Equities Analysts Set Expectations for RNTX FY2026 Earnings

HC Wainwright has updated its FY2026 earnings forecast for Rein Therapeutics (NASDAQ:RNTX), narrowing the projected loss per share to $0.47 from $0.53 and maintaining a "Buy" rating. This adjustment follows Rein Therapeutics' reported quarterly loss of $0.10 per share, which significantly beat analyst expectations. …

Lisanti Capital Growth LLC Acquires Shares of 20,825 Axsome Therapeutics, Inc. $AXSM

Lisanti Capital Growth LLC acquired a new position of 20,825 shares in Axsome Therapeutics, Inc. (NASDAQ:AXSM) valued at approximately $5.1 million during the second quarter. This move is part of broader institutional investment, with BlackRock also establishing a significant new position, bringing total institutional …

Gyre Therapeutics (NASDAQ:GYRE) Lowered to "Strong Sell" Rating by Zacks Research

Zacks Research downgraded Gyre Therapeutics (NASDAQ:GYRE) from a "hold" to a "strong sell" rating, with other firms also issuing negative ratings, though the overall analyst consensus remains "hold" with a $17 target price. The company reported a quarterly loss of $0.12 per share, missing …

Bicara Therapeutics (NASDAQ:BCAX) Raised to "Strong-Buy" at BMO Capital Markets

BMO Capital Markets upgraded Bicara Therapeutics (NASDAQ:BCAX) to a "strong-buy" rating, with other analysts maintaining a "Moderate Buy" consensus and an average target price of $32.64. The company's shares rose by 3.8% to $25.86, following a quarterly EPS report of negative $0.82, which met …

77,500 Shares in IPG Photonics Corporation $IPGP Bought by Westport Asset Management Inc.

Westport Asset Management Inc. acquired 77,500 shares of IPG Photonics Corporation (NASDAQ:IPGP) in the second quarter, valuing its stake at approximately $9.1 million. This makes IPG Photonics the 6th largest position in Westport's portfolio. The company has a "Moderate Buy" consensus rating from analysts, …

Halozyme Therapeutics (HALO) Adds A New Director, Is It 21% Overvalued?

Halozyme Therapeutics (HALO) recently elected Dannielle Appelhans to its Board of Directors, following strong share price returns, increased revenue, and ongoing buybacks. While analysts generally view HALO as 20.7% overvalued with a fair value of $86.89, a Discounted Cash Flow (DCF) model by Simply …

HC Wainwright Has Bearish Forecast for ELTX Q3 Earnings

Oruka (ORKA) Earnings Snapshot: The Available Earnings Metric Delivers a Miss in the Available Record; Post-Report: Shares Finish 3.00% Down for the Current Session - Earnings Cycle Outlook

Intellia (NTLA) Results Review: Reported EPS Tops Expectations on the Day; Session Move

Tieton Capital Management LLC Makes New $11.88 Million Investment in Texas Capital Bancshares, Inc. $TCBI

Tieton Capital Management LLC has made a new $11.88 million investment in Texas Capital Bancshares, acquiring 115,045 shares, making it their 11th largest holding. The article highlights that institutional investors collectively own 96.88% of the stock, while analysts generally maintain a "Hold" rating with …

Qnity Accelerates Advanced Node Materials Innovation with Next-Generation KLA Inspection Capabilities

Qnity Electronics has installed a KLA Surfscan SP7XP unpatterned wafer defect inspection system to bolster its advanced semiconductor materials innovation. This new system, located at Qnity's New England Manufacturing & Technology Center, enhances the company's ability to develop and manufacture leading-edge materials and deepen …

Viking Therapeutics (NASDAQ:VKTX) Upgraded to Hold at Zacks Research

Zacks Research has upgraded Viking Therapeutics (NASDAQ:VKTX) from a "strong sell" to a "hold" rating, though the broader analyst consensus remains a "Moderate Buy" with a target price of $96.62. The company's stock rose 7.8% on Tuesday after exceeding quarterly loss expectations. Despite recent …

Verisk Analytics (VRSK) Receives a Buy from RBC Capital

RBC Capital analyst Ashish Sabadra maintained a Buy rating on Verisk Analytics (VRSK) with a price target of $230.00. The company's shares closed yesterday at $178.86. Despite negative insider sentiment with an increase in insider selling, the company reported quarterly revenue of $806.3 million …

Northwest (NWBI) Earnings Snapshot: EPS Beats Its Estimate in the Latest Reading; Price Reaction: The Market Price Declines 2.37% on the Day - Earnings Risk Report

Context (CNTX) Quarterly Figures: EPS Comes in Below Forecast for This Review; Post-Earnings: Shares Fall 1.81%

Telefonica Chile signs multi-year Amdocs deal to accelerate network modernisation

Telefonica Chile has signed a multi-year managed services agreement with Amdocs to streamline its technology operations and accelerate modernization under its new owner, Millicom. This partnership will involve Amdocs' business and operations support systems, AI-driven application management, operations services, and software development. The collaboration …

VSTECS H1 2026 slides: 50% profit surge raises sustainability questions

CRISM Therapeutics Starts Phase II ChemoSeed Trial in Glioblastoma

CRISM Therapeutics begins patient recruitment for Phase II glioblastoma trial By Investing.com

Mitsubishi UFJ Asset Management Co. Ltd. Acquires Shares of 268,354 Quest Diagnostics Incorporated $DGX

Mitsubishi UFJ Asset Management Co. Ltd. has acquired a new stake of 268,354 shares in Quest Diagnostics Incorporated, valued at approximately $56.88 million, representing 0.24% of the company. Other institutional investors have also adjusted their holdings in DGX. Wall Street analysts have issued various …

REG - CRISM Therapeutics - Commencement of Patient Recruitment

Wealthfront Advisers LLC Makes New Investment in Quest Diagnostics Incorporated $DGX

Wealthfront Advisers LLC has made a new investment in Quest Diagnostics (NYSE:DGX), purchasing 34,789 shares valued at approximately $7.4 million in the second quarter. Institutional investors now own 88.06% of the company. Quest Diagnostics recently reported strong quarterly earnings, surpassing analyst estimates, and announced …

Earnings call transcript: VSTECS H1 2026 profit jumps 50% as shares fall

Wealthfront Advisers LLC Buys Shares of 160,086 CSX Corporation $CSX

Wealthfront Advisers LLC recently acquired 160,086 shares of CSX Corporation, valued at approximately $7.6 million, during the second quarter, contributing to institutional investors owning 73.57% of the company's stock. CSX reported strong Q2 earnings, exceeding analyst estimates with $0.54 EPS and $3.94 billion in …

China Infrastructure & Logistics Group in Five-Year Port Coatings Pact to Drive New Growth

Iovance Biotherapeutics (IOVA) Stock Could Be Rich Following Its 217% Run

Handelsbanken Fonder AB Buys New Shares in Enliven Therapeutics, Inc. $ELVN

Handelsbanken Fonder AB acquired 17,300 shares of Enliven Therapeutics, Inc. (NASDAQ:ELVN) valued at approximately $878,000 during the second quarter. Institutional investors and hedge funds now collectively own 95.08% of the company's stock, while insider transactions show sales totaling $11.3 million over the past 90 …

Form 144 | Veradermics(MANE.US) Insider Proposes to Sell 6.37 Million in Common Stocks

An insider at Veradermics (MANE.US) has filed a Form 144, indicating a proposal to sell 6.37 million common stocks. This filing provides notice of the individual's intent to sell a significant number of shares in the company.

Royal Bank of Canada Has $1.60 Million Stock Holdings in Dianthus Therapeutics, Inc. $DNTH

Royal Bank of Canada significantly increased its stake in Dianthus Therapeutics, Inc. by 847.5% in the first quarter, now holding 19,064 shares valued at $1.60 million. Despite the company missing EPS estimates, institutional investors collectively own 47.53% of the stock, and Wall Street analysts …

China Infrastructure & Logistics forecasts 225% profit surge on terminal-focused strategy

Radiopharm Theranostics Advances 177Lu-RAD202 to Cohort 4 in Phase 1 HEAT Clinical Trial

Radiopharm Theranostics (ASX:RAD) has received a positive recommendation from its Data Safety and Monitoring Committee to advance its radiotherapeutic asset 177Lu-RAD202 to the next dose level in the Phase 1 'HEAT' clinical trial. This advancement to Cohort 4, at a dose of 180mCi, is …

Handelsbanken Fonder AB Purchases Shares of 19,400 Structure Therapeutics Inc. Sponsored ADR $GPCR

Handelsbanken Fonder AB recently acquired 19,400 shares of Structure Therapeutics Inc. Sponsored ADR (GPCR) for approximately $1.04 million in the second quarter. Institutional investors now collectively own 91.78% of the company's stock. Despite missing earnings estimates in its last report, analysts have a "Moderate …

Telefonaktiebolaget LM Ericsson Class A Revenue Breakdown – OMXSTO:ERIC_A

Telefonaktiebolaget LM Ericsson Class A (OMXSTO:ERIC_A) generated a total revenue of 236.68 billion SEK last year. The Networks segment was the top performer, contributing 151.01 billion SEK, while the United States was the largest regional contributor with 96.47 billion SEK.